Oui Health

Oui Therapeutics is a digital therapeutics company that has developed a prescription-based mobile application, Aviva, to aid individuals who have experienced a suicidal crisis. The application is designed to be a directed and personalized program to help users manage distressing thoughts and is based on clinically trialed science.

The company operates in the behavioral healthcare market, with a specific focus on suicide prevention. Its business model is centered around the development and distribution of FDA-regulated digital therapeutics. The primary clients for Oui Therapeutics are payers within the healthcare ecosystem, such as health insurers. By providing a scalable and accessible solution, the company aims to address the significant challenge of suicide, a highly misunderstood public health issue.

Founded in 2018, the New Haven-based company has reached the Series B funding stage, backed by a team of experts in digital therapy and suicide prevention. The company's approach is to combine scientific research with technology to create life-saving interventions for at-risk populations.

Keywords: digital therapeutics, suicide prevention, behavioral healthcare, prescription digital therapeutic, mobile application, mental health, healthcare technology, FDA-regulated, health insurers, Series B